BioInnovation Capital
Venture capitalCambridge · 1 people tracked
Fund manager profile
BioInnovation Capital is a venture fund manager based in Cambridge. SEC filings show 1 venture fund on record, most recently BioInnovation Capital I LP filed February 2017.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directories
What they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathBiotechDurham, US
Edward Field(Executive Officer, Director)Susie Harborth(Director)Kimberly Blackwell(Executive Officer)Michael Zalutsky(Executive Officer, Director)Bill Hawkins(Director)
Board seatEric Linsley· per SEC Form D · $6M raise · filed Aug 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- Where is BioInnovation Capital located?
- BioInnovation Capital is headquartered in Cambridge, US.
Co-investors · 3
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
NewView Capital is a venture capital firm that provides flexible capital to growth-stage companies, investing on a primary, secondary, or hybrid basis and offering operational guidance on scale-up decisions.
Domain Associates is a venture capital firm founded in 1985 that invests in life sciences companies. The firm operates as a limited liability company.
Firms observed investing alongside BioInnovation Capital, from public investor directories. Shared companies are the overlap with BioInnovation Capital's recorded portfolio.